Dermira, Inc.
Overview
Dermira, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for dermatologic diseases. It operates as a subsidiary of Eli Lilly and Company, aiming to address unmet needs in the treatment of chronic skin conditions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Dermira, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.